07:00 , May 30, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Lysine-specific demethylase 4A (KDM4A; JMJD2A); jun (AP1) proto-oncogene Cell culture...
07:00 , Jul 19, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Squamous cell carcinoma (SCC); basal cell carcinoma (BCC) Jun (AP1) proto-oncogene Mouse...
08:00 , Feb 14, 2008 |  BC Innovations  |  Targets & Mechanisms

Cancerous RAGE

Mounting evidence has linked chronic inflammation and cancer, but the sheer number of pathways and molecules that could be involved has slowed the identification of the molecular mechanisms that may lead inflamed tissue to become...
07:00 , Jun 28, 2004 |  BioCentury  |  Strategy

Dermatology lineup

Dermatology lineup Marketed products Product Indication Market 2003 revs Advantan Eczema EU & Latin America E35M ($44M) Nerisona Eczema and psoriasis Asia, Japan, Latin America E24M ($30M) (A) Travogen Dermatomycoses EU, Latin America & Asia...